Articles from BioResearch Compliance Report (November 1, 2007)

Title	Author	Type	Words
Be wary of lavish payments to clinical investigators, PhRMA provides helpful guidelines.	Pickett, Joseph		517
BiMo inspection FOIA log.			257
Compliance assessment avoids harsh criminal penalties.	Pickett, Joseph		476
Cutting-edge investigator training vital to protect human safety, particularly in wake of new I.G. report.	Pickett, Joseph		549
Drug safety needs proactive risk minimization planning, Bristol-Myers exec says.	Pickett, Joseph		552
IRB determination letters.			62
Open communication of clinical trial data related to off-label use essential.	Pickett, Joseph		512
Warning letters.			599